A nuclear targeting system in <it>Plasmodium falciparum</it>

A nuclear targeting system in <it>Plasmodium falciparum</it>

<p>Abstract</p> <p>Background</p> <p>The distinct differences in gene control mechanisms acting in the nucleus between <it>Plasmodium falciparum </it>and the human host could lead to new potential drug targets for anti-malarial development. New molecular too...

Full description

Bibliographic Details
Main Authors:	Kochakarn Theerarat, Songprakhon Pucharee, Tinikul Ruchanok, Kumpornsin Krittikorn, Uthaipibull Chairat, Wittayacom Kanjana, Chookajorn Thanat
Format:	Article
Language:	English
Published:	BMC 2010-05-01
Series:	Malaria Journal
Online Access:	http://www.malariajournal.com/content/9/1/126

Similar Items

Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum
by: Krittikorn Kümpornsin, et al.
Published: (2023-05-01)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
by: Aiyada Aroonsri, et al.
Published: (2019-04-01)

Fitness loss under amino acid starvation in artemisinin-resistant Plasmodium falciparum isolates from Cambodia
by: Bunditvorapoom, D, et al.
Published: (2018)

Selection of drug resistant mutants from random library of <it>Plasmodium falciparum </it>dihydrofolate reductase in <it>Plasmodium berghei </it>model
by: Yuthavong Yongyuth, et al.
Published: (2011-05-01)

Overexpression of plasmepsin II and plasmepsin III does not directly cause reduction in Plasmodium falciparum sensitivity to artesunate, chloroquine and piperaquine
by: Loesbanluechai, D, et al.
Published: (2018)

Identifying transcript 5′ capped ends in Plasmodium falciparum
by: Philip J. Shaw, et al.
Published: (2021-08-01)

Genome-wide functional screening of drug-resistance genes in Plasmodium falciparum
by: Shiroh Iwanaga, et al.
Published: (2022-10-01)

Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage
by: Kümpornsin, K, et al.
Published: (2021)

Deletion of Plasmodium falciparum ubc13 increases parasite sensitivity to the mutagen, methyl methanesulfonate and dihydroartemisinin
by: Supawadee Maneekesorn, et al.
Published: (2021-11-01)

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
by: Pitchayathida Mee-udorn, et al.
Published: (2023-09-01)

How to combat emerging artemisinin resistance: Lessons from "The Three Little Pigs".
by: Thanat Chookajorn
Published: (2018-04-01)

Bridging the Gap: Can COVID-19 Research Help Combat African Swine Fever?
by: Danaya Pakotiprapha, et al.
Published: (2023-09-01)

Microbial degradation of halogenated aromatics: molecular mechanisms and enzymatic reactions
by: Panu Pimviriyakul, et al.
Published: (2020-01-01)

Apicoplast ribosomal protein S10-V127M enhances artemisinin resistance of a Kelch13 transgenic Plasmodium falciparum
by: Tanyaluck Kampoun, et al.
Published: (2022-10-01)

Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum
by: Tanyaluck Kampoun, et al.
Published: (2023-04-01)

Transgenic <it>Plasmodium </it>parasites stably expressing <it>Plasmodium vivax </it>dihydrofolate reductase-thymidylate synthase as <it>in vitro </it>and <it>in vivo </it>models for antifolate screening
by: Yuthavong Yongyuth, et al.
Published: (2011-10-01)

Alpha-mangostin inhibits viral replication and suppresses nuclear factor kappa B (NF-κB)-mediated inflammation in dengue virus infection
by: Mayuri Tarasuk, et al.
Published: (2022-09-01)

Comparative genome-wide analysis and evolutionary history of haemoglobin-processing and haem detoxification enzymes in malarial parasites.
by: Ponsuwanna, P, et al.
Published: (2016)

Correction: Role of human heterogeneous nuclear ribonucleoprotein C1/C2 in dengue virus replication
by: Thanyaporn Dechtawewat, et al.
Published: (2024-02-01)

Ubiquitin activation is essential for schizont maturation in Plasmodium falciparum blood-stage development.
by: Judith L Green, et al.
Published: (2020-06-01)

Multicopy targets for Plasmodium vivax and Plasmodium falciparum detection by colorimetric LAMP
by: Oscar Nolasco, et al.
Published: (2021-05-01)

Combined treatment of 3-hydroxypyridine-4-one derivatives and green tea extract to induce hepcidin expression in iron-overloaded β-thalassemic mice
by: Supranee Upanan, et al.
Published: (2015-12-01)

Cellular responses to modified <it>Plasmodium falciparum </it>MSP1<sub>19 </sub>antigens in individuals previously exposed to natural malaria infection
by: Awobode Henrietta O, et al.
Published: (2009-11-01)

Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria
by: Boyle, MJ, et al.
Published: (2016)

Identification of proteins targeted by the thioredoxin superfamily in Plasmodium falciparum.
by: Nicole Sturm, et al.
Published: (2009-04-01)

Malária grave por Plasmodium falciparum Severe Plasmodium falciparum malaria
by: Andréia Patrícia Gomes, et al.
Published: (2011-09-01)

Identification of Plasmodium falciparum nuclear proteins by mass spectrometry and proposed protein annotation.
by: Sylvie Briquet, et al.
Published: (2018-01-01)

Evolução dos gametos do Plasmodium falciparum Evolution of the gametes of Plasmodium falciparum
by: Henrique de Beaurepaire Aragão
Published: (1930-09-01)

Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase
by: Stanley C. Xie, et al.
Published: (2024-01-01)

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets
by: Longley, R, et al.
Published: (2015)

In silico drug discovery: Unveiling potential targets in Plasmodium falciparum
by: R. Murugesan, et al.
Published: (2024-06-01)

Antimalarial target vulnerability of the putative Plasmodium falciparum methionine synthase
by: Nirut Leela, et al.
Published: (2024-01-01)

In vitro mutagenesis defines drug targets in adolase of Plasmodium falciparum
by: Ulrich Certa, et al.
Published: (1992-01-01)

Mitochondrially targeted proximity biotinylation and proteomic analysis in Plasmodium falciparum.
by: Ian M Lamb, et al.
Published: (2022-01-01)

Targeting NAD+ metabolism in the human malaria parasite Plasmodium falciparum.
by: Jessica K O'Hara, et al.
Published: (2014-01-01)

The Plasmodium berghei RC strain is highly diverged and harbors putatively novel drug resistance variants
by: Warangkhana Songsungthong, et al.
Published: (2017-10-01)

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
by: Roth, A, et al.
Published: (2018)

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum
by: Alison Roth, et al.
Published: (2018-05-01)

Development of an inducible transcriptional control system in plasmodium falciparum with applications to targeted genome editing
by: Wagner, Jeffrey C. (Jeffrey Charles)
Published: (2014)

Malária por Plasmodium falciparum: estudos proteômicos Plasmodium falciparum malaria: proteomic studies
by: Rodrigo Siqueira-Batista, et al.
Published: (2012-12-01)